Trial intelligence / Profile preview

Cinaciguat in Decompensated Chronic Congestive Heart Failure

NCT00559650Phase 2Terminated

Sponsor
Bayer
Start
Dec 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
17
01

Overview

A Phase 2 trial of cinaciguat in heart failure (HF), sponsored by Bayer. Started Dec 2007; status: terminated.

02

Drugs

cinaciguat
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00559650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00559650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call